Vuong Trieu
CHAIRMAN AND CEO, Director, 10% Owner · Oncotelic Therapeutics, Inc.
- 2024
- Oct 30, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vuong Trieu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amit B. Shah - $1K in OTLC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vuong Trieu?
Vuong Trieu is a corporate insider, tracked as CHAIRMAN AND CEO, Director, 10% Owner of Oncotelic Therapeutics, Inc. (OTLC). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vuong Trieu submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Vuong Trieu been buying or selling stock?
Recorded transactions: 12 open-market purchases ($70K) and 0 open-market sales across all tracked filings.
